Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine
DeviceTalks Podcast Network
Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Jul 23 2021 | 00:42:16

/
Episode • July 23, 2021 • 00:42:16

Hosted By

Kayleen Brown Tom Salemi

Show Notes

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Previous Episode

Hear from the CEOs of two surgical robotics companies that together just raised over $1 billion

Next Episode

What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

Other Episodes

August 12, 2022

DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post

In this replay of our most recent MedtronicTalks episode, Dr. Laura Mauri shares the career path that started with an early interest in medicine...

Play

00:35:20

June 14, 2024

OIV’s Hunter-Syed on corporate venture capital’s growing influence; Bell previews SRS annual meeting

In this week’s DeviceTalks Weekly Podcast, we dig deeper into the worlds of Corporate Venture Capital and Surgical Robotics. In our keynote interviews, Host...

Play

00:47:36

February 02, 2024

Medtronic’s Jason Weidman recalls the long, bumpy road to getting FDA approval for Symplicity Spiral

This week’s DeviceTalks Weekly is a bit of a retrospective on Medtronic’s Symplicity Spiral Renal Denervation System. It obviously ends on a happy note,...

Play

01:03:13